Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Prepaid Assets (2020 - 2025)

Candel Therapeutics' Prepaid Assets history spans 4 years, with the latest figure at $1.4 million for Q4 2023.

  • On a quarterly basis, Prepaid Assets fell 26.66% to $1.4 million in Q4 2023 year-over-year; TTM through Dec 2023 was $1.4 million, a 26.66% decrease, with the full-year FY2023 number at $1.4 million, down 26.66% from a year prior.
  • Prepaid Assets hit $1.4 million in Q4 2023 for Candel Therapeutics, down from $2.1 million in the prior quarter.
  • Over the last five years, Prepaid Assets for CADL hit a ceiling of $2.6 million in Q1 2023 and a floor of $93000.0 in Q4 2020.
  • Historically, Prepaid Assets has averaged $1.5 million across 4 years, with a median of $1.7 million in 2022.
  • Biggest five-year swings in Prepaid Assets: surged 2376.34% in 2021 and later dropped 26.66% in 2023.
  • Tracing CADL's Prepaid Assets over 4 years: stood at $93000.0 in 2020, then surged by 2376.34% to $2.3 million in 2021, then fell by 18.06% to $1.9 million in 2022, then dropped by 26.66% to $1.4 million in 2023.
  • Business Quant data shows Prepaid Assets for CADL at $1.4 million in Q4 2023, $2.1 million in Q3 2023, and $1.5 million in Q2 2023.